10.09.2014 22:48:37
|
Baxter Reveals Name Of New Global Biopharmaceutical Company
(RTTNews) - Baxter International Inc. (BAX) said Wednesday that Baxalta Inc. will be the name of the new, publicly traded biopharmaceutical company that is expected to launch in mid-2015.
Upon completion of the separation, Baxalta plans to trade on the New York Stock Exchange under the symbol BXLT. Baxter International will continue trading on the NYSE under the symbol BAX.
The corporate headquarters of both companies will be located in northern Illinois.
In March, Baxter announced its plan to separate into two healthcare companies - one focused on developing biopharmaceuticals and the other on medical products.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Baxter International Inc.mehr Nachrichten
Analysen zu Baxter International Inc.mehr Analysen
Aktien in diesem Artikel
Baxter International Inc. | 30,06 | -0,66% |
|